BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23723077)

  • 1. Unraveling the role of FOXQ1 in colorectal cancer metastasis.
    Abba M; Patil N; Rasheed K; Nelson LD; Mudduluru G; Leupold JH; Allgayer H
    Mol Cancer Res; 2013 Sep; 11(9):1017-28. PubMed ID: 23723077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1.
    Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L
    Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
    Nam EH; Lee Y; Moon B; Lee JW; Kim S
    Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.
    Meng F; Speyer CL; Zhang B; Zhao Y; Chen W; Gorski DH; Miller FR; Wu G
    Cancer Res; 2015 Feb; 75(3):584-93. PubMed ID: 25502837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
    Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
    Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
    Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
    Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
    Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
    Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
    Liu Y; Mayo MW; Xiao A; Hall EH; Amin EB; Kadota K; Adusumilli PS; Jones DR
    Mol Cell Biol; 2015 Jan; 35(1):303-17. PubMed ID: 25368381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells.
    Shen X; Hu X; Mao J; Wu Y; Liu H; Shen J; Yu J; Chen W
    Cell Death Dis; 2020 Jan; 11(1):65. PubMed ID: 31988275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The twist box domain is required for Twist1-induced prostate cancer metastasis.
    Gajula RP; Chettiar ST; Williams RD; Thiyagarajan S; Kato Y; Aziz K; Wang R; Gandhi N; Wild AT; Vesuna F; Ma J; Salih T; Cades J; Fertig E; Biswal S; Burns TF; Chung CH; Rudin CM; Herman JM; Hales RK; Raman V; An SS; Tran PT
    Mol Cancer Res; 2013 Nov; 11(11):1387-400. PubMed ID: 23982216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
    Pei XH; Lv XQ; Li HX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
    Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
    Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
    Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
    Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
    Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
    Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen α1(VI).
    García-Palmero I; Torres S; Bartolomé RA; Peláez-García A; Larriba MJ; Lopez-Lucendo M; Peña C; Escudero-Paniagua B; Muñoz A; Casal JI
    Oncogene; 2016 Oct; 35(40):5224-5236. PubMed ID: 26973246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation.
    Ma G; He J; Yu Y; Xu Y; Yu X; Martinez J; Lonard DM; Xu J
    Int J Biol Sci; 2015; 11(5):618-28. PubMed ID: 25892968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.